Cygnus Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Cygnus Capital Advisors, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $5K in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$5K
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 142,800 | $4K |
| ZYMEZymeworks Inc. | 8,197 | $205 |
| SIONSionna Therapeutics, Inc. | 3,800 | $152 |
| IMNMImmunome Inc. | 6,880 | $150 |
| CYPHCYPHERPUNK TECHNOLOGIES INC. | 11,492 | $135 |
| ANNXAnnexon, Inc. | 22,200 | $123 |
| EWTXEdgewise Therapeutics, Inc. | 3,427 | $108 |
| CMPXCompass Therapeutics, Inc. | 18,000 | $95 |
| RANIRani Therapeutics Holdings, Inc. | 115,649 | $85 |
| FOLDAMICUS THERAPEUTICS, INC. | 4,082 | $59 |
| MBXMBX Biosciences, Inc. | 1,800 | $54 |
| NRIXNurix Therapeutics, Inc. | 3,300 | $51 |
| STOKStoke Therapeutics, Inc. | 1,500 | $49 |
| TXMDTherapeuticsMD, Inc. | 9,069 | $18 |
| NUVBNuvation Bio Inc. | 3,872 | $17 |
| KURAKura Oncology, Inc. | 1,788 | $15 |
| VSTMVerastem, Inc. | 1,894 | $10 |
| ALLOAllogene Therapeutics, Inc. | 3,234 | $8 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.